Plus, why a Top 3% analyst at one of Wall Street’s biggest banks is still backing Nvidia...
Plus, a top-1% initiation on a battered AI networking chipmaker...
One stock pick from a top-ranked analyst with an implied upside of 100% or more.
Plus, a broker whose betting arm now outearns crypto...
Plus, Alphabet's likely top optical switch supplier...
Plus, a Top 2% analyst's call on a fallen biotech leader...
Plus, a new Alzheimer's play with a brain-shuttle edge...
Plus, a vaccine maker weeks from its pivotal test....
Plus, a precision medicine company betting on human genetics....
Plus, a Top 1% analyst's Street-high edge-AI call...
Plus, the largest US gas producer at a peer discount...
Plus, a surprising med-tech name riding the GLP-1 boom...
September is historically the market's worst month. Here's where the money may be hiding.
Plus, a cancer-imaging play with a looming FDA date... and a whopping 95% implied upside.